Abstract
There are contradictory opinions if late-onset systemic lupus erythematosus (SLE) is associated with a different, more benign disease course and better prognosis than early-onset SLE. The objective of this study was to evaluate the clinical manifestations, course, treatment, and prognosis of late-onset SLE. Patients who developed SLE after/or at the age of 50 years were considered late-onset SLE and compared to a group of randomly selected patients aged younger than 50 years at the diagnosis, matched for disease duration. Lower frequency of cutaneous manifestations (p = 0.01) and higher frequency of cytopenias (p = 0.02) were registrated at the SLE onset in the late-onset group. Atypical clinical presentation of SLE contributed to a longer delay of diagnosis in late-onset SLE patients (p = 0.005), who fullfiled less American College of Rheumatology criteria at the diagnosis (p = 0.022). Cumulative incidence of clinical manifestations showed lower frequency of cutaneous (p = 0.017), neuropsychiatric manifestations (p = 0.021), lupus nephritis (p = 0.006), and higher frequency of Sjogren′s syndrome (p = 0.025) in the late-onset group. Late-onset SLE patients received lower doses of corticosteroid (p = 0.006) and cyclophosphamide (p = 0.001) and had more cyclophosphamide-induced complications (p = 0.005). Higher prevalence of comorbid conditions in the late-onset group (p = 0.025), and higher Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index was noticed (p = 0.018). Despite the less major organ involvement and more benign course of disease, late-onset SLE has poorer prognosis, because of the higher frequency of comorbid conditions and higher organ damage, due to the aging and longer exposition to a classical vascular risk factors.
Similar content being viewed by others
References
Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC (2004) Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in literature. Medicine (Baltimore) 83:348–359
Appenzeller S, Pereira DA, Costallat LT (2008) Greater accrual damage in late-onset systemic lupus erythematosus: long-term follow-up study. Lupus 17(11):1023–1028
Padovan M, Govoni M, Castellino G, Rizzo N, Fotinidi M, Trotta F (2007) Late oneset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int 27(8):735–741
Formiga F, Moga I, Pac M, Mitjava F, Rivera A, Rujol R (1999) Mild presentation of systemic lupus erythematosus in elderly patients assesed by SLEDAI. SLE Disease Activity Index. Lupus 8(6):462–465
Maddison P, Farewell V, Isenberg D (2002) The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29:913–917
Bertoli AM, Alacron GS, Calvo-Alen J, Fernandez M, Vila LM, Reveille JD (2006) LUMINA Study Group. Systemic lupus etrythematosus in multietnic US cohort. XXXIII. Clinical features, course and outcome in patients with late-onset disease. Arthritis Rheum 54(5):1580–1587
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothefield NF (1982) The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Mak SK, Lam EKM, Wong AKM (1998) Clinical profile of patients with late onset SLE: not a benign subgroup. Lupus 7:23–28
Gladman D, Gentler E, Goldsmith C, Fortin P, Liang M, Hurwitz M, Bacon P et al (1996) The development and initial validation of Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexande EL, Carsons SE et al (2002) European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558
Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Hemost 74:1185–1190
Ward MM, Polisson RP (1989) Manifestations of older-onset systhemic lupus erythematosus. Arthritis Rheum 32:1226–1232
Rovensky J, Tuchynova A (2008) Systemic lupus erythematosus in the elderly. Autoimmunity Rev 7:235–239
Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long term survival of Southern Chinese patients with systemic lupus erythematosus. Medicine Balthimore 84(4):218–224
Kammer GM, Mishira N (2000) Systemic lupus erythematosus in the elderly. Rheum Dis Clin N Amer 26:475–492
Lalani S, Pope J, de Leon F, Peschen C (2010) Clinical features and prognosis of late oneset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumathol 37(1):38–44
Cervera K, Khamashta MA, Font J (1993) Systemic lupus erythematosus in elderly patients, in cohort of 1000 patients. Medicine 72:113–124
Lazaro D (2007) Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment. Drugs Aging 24(9):701–715
Ramos-Casals M, Garcia-Carraso M, Brito MP, Lopez-Soto A, Font J (2003) Immunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus 12(5):341–355
Manager K, Manager B, Repp R, Geissellbrecht M, Geiger A, Pfahlberg A et al (2002) Definition of risk factors for death end stage renal disease, and thromboembolic events in monoconcentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065–1070
Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S et al (2003) Premature coronary artery atherosclerosis in systemic lupus erythematosus. N Eng J Med 394:2407–2415
Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R et al (2003) Prevalence and correlates of accelerated atherosclerosis in systhemic lupus erythematosus. N Eng J Med 349:2399–2406
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tomic-Lucic, A., Petrovic, R., Radak-Perovic, M. et al. Late-onset systemic lupus erythematosus: clinical features, course, and prognosis. Clin Rheumatol 32, 1053–1058 (2013). https://doi.org/10.1007/s10067-013-2238-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2238-y